Recent advances in bioactive microbial secondary metabolites
- PMID: 77338
Recent advances in bioactive microbial secondary metabolites
Similar articles
-
Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.Biomedicine. 1977 Jul;26(4):236-49. Biomedicine. 1977. PMID: 72569
-
[Some problems in finding and in the microbiological synthesis of physiologically active compounds].Antibiotiki. 1975 Oct;20(10):948-56. Antibiotiki. 1975. PMID: 1211893 Russian. No abstract available.
-
Studies on bioactive compounds from microorganisms.Kitasato Arch Exp Med. 1984 Jun;57(2):75-204. Kitasato Arch Exp Med. 1984. PMID: 6397654 Review. No abstract available.
-
[Research progress of secondary metabolites produced by microorganisms--enzyme inhibitors (author's transl)].Tanpakushitsu Kakusan Koso. 1976 Oct;21(10):776-90. Tanpakushitsu Kakusan Koso. 1976. PMID: 186848 Review. Japanese. No abstract available.
-
Small molecular microbial products enhancing immune response.Antibiot Chemother (1971). 1978;24:9-18. doi: 10.1159/000401495. Antibiot Chemother (1971). 1978. PMID: 655681
Cited by
-
Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.Jpn J Surg. 1990 Mar;20(2):186-91. doi: 10.1007/BF02470767. Jpn J Surg. 1990. PMID: 2111415 Clinical Trial.
-
What are secondary metabolites?Folia Microbiol (Praha). 1979;24(5):435-43. doi: 10.1007/BF02927127. Folia Microbiol (Praha). 1979. PMID: 527915 No abstract available.
-
Characterization of a protease apparently involved in processing of pre-ornithine transcarbamylase of rat liver.Proc Natl Acad Sci U S A. 1980 Dec;77(12):7044-8. doi: 10.1073/pnas.77.12.7044. Proc Natl Acad Sci U S A. 1980. PMID: 7012832 Free PMC article.
-
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.Cancer Immunol Immunother. 1987;25(1):41-6. doi: 10.1007/BF00199299. Cancer Immunol Immunother. 1987. PMID: 3594491 Free PMC article. Clinical Trial.
-
Green extraction of puromycin-based antibiotics from Streptomyces albofaciens (MS38) for sustainable biopharmaceutical applications.Front Chem. 2024 Jan 9;11:1326328. doi: 10.3389/fchem.2023.1326328. eCollection 2023. Front Chem. 2024. PMID: 38264123 Free PMC article.